vs
Side-by-side financial comparison of Civeo Corp (CVEO) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $161.6M, roughly 1.3× Civeo Corp). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -4.0%, a 6.7% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 7.1%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -1.4%).
The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
CVEO vs IRTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $161.6M | $208.9M |
| Net Profit | $-6.5M | $5.6M |
| Gross Margin | 22.7% | 70.9% |
| Operating Margin | -0.1% | 1.1% |
| Net Margin | -4.0% | 2.7% |
| Revenue YoY | 7.1% | 27.1% |
| Net Profit YoY | 58.1% | 518.5% |
| EPS (diluted) | $-0.58 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $161.6M | $208.9M | ||
| Q3 25 | $170.5M | $192.9M | ||
| Q2 25 | $162.7M | $186.7M | ||
| Q1 25 | $144.0M | $158.7M | ||
| Q4 24 | $151.0M | $164.3M | ||
| Q3 24 | $176.3M | $147.5M | ||
| Q2 24 | $188.7M | $148.0M | ||
| Q1 24 | $166.1M | $131.9M |
| Q4 25 | $-6.5M | $5.6M | ||
| Q3 25 | $-455.0K | $-5.2M | ||
| Q2 25 | $-3.3M | $-14.2M | ||
| Q1 25 | $-9.8M | $-30.7M | ||
| Q4 24 | $-15.4M | $-1.3M | ||
| Q3 24 | $-5.1M | $-46.2M | ||
| Q2 24 | $8.2M | $-20.1M | ||
| Q1 24 | $-5.1M | $-45.7M |
| Q4 25 | 22.7% | 70.9% | ||
| Q3 25 | 25.7% | 71.1% | ||
| Q2 25 | 25.3% | 71.2% | ||
| Q1 25 | 20.4% | 68.8% | ||
| Q4 24 | 18.6% | 70.0% | ||
| Q3 24 | 21.4% | 68.8% | ||
| Q2 24 | 25.4% | 69.9% | ||
| Q1 24 | 21.5% | 66.3% |
| Q4 25 | -0.1% | 1.1% | ||
| Q3 25 | 4.1% | -4.4% | ||
| Q2 25 | 1.7% | -10.0% | ||
| Q1 25 | -3.8% | -20.5% | ||
| Q4 24 | -6.7% | -2.5% | ||
| Q3 24 | 0.0% | -34.1% | ||
| Q2 24 | 6.9% | -15.5% | ||
| Q1 24 | -1.1% | -28.9% |
| Q4 25 | -4.0% | 2.7% | ||
| Q3 25 | -0.3% | -2.7% | ||
| Q2 25 | -2.0% | -7.6% | ||
| Q1 25 | -6.8% | -19.3% | ||
| Q4 24 | -10.2% | -0.8% | ||
| Q3 24 | -2.9% | -31.3% | ||
| Q2 24 | 4.4% | -13.6% | ||
| Q1 24 | -3.1% | -34.6% |
| Q4 25 | $-0.58 | $0.18 | ||
| Q3 25 | $-0.04 | $-0.16 | ||
| Q2 25 | $-0.25 | $-0.44 | ||
| Q1 25 | $-0.72 | $-0.97 | ||
| Q4 24 | $-1.04 | $-0.03 | ||
| Q3 24 | $-0.36 | $-1.48 | ||
| Q2 24 | $0.56 | $-0.65 | ||
| Q1 24 | $-0.35 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.4M | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $174.4M | $152.7M |
| Total Assets | $477.4M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $583.8M | ||
| Q3 25 | $12.0M | $565.2M | ||
| Q2 25 | $14.6M | $545.5M | ||
| Q1 25 | $28.4M | $520.6M | ||
| Q4 24 | $5.2M | $535.6M | ||
| Q3 24 | $17.9M | $522.0M | ||
| Q2 24 | $7.4M | $561.5M | ||
| Q1 24 | $16.8M | $569.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $43.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $174.4M | $152.7M | ||
| Q3 25 | $182.5M | $121.9M | ||
| Q2 25 | $209.4M | $103.7M | ||
| Q1 25 | $220.7M | $86.7M | ||
| Q4 24 | $236.4M | $90.9M | ||
| Q3 24 | $282.2M | $71.8M | ||
| Q2 24 | $297.4M | $99.2M | ||
| Q1 24 | $297.4M | $90.3M |
| Q4 25 | $477.4M | $1.0B | ||
| Q3 25 | $491.1M | $995.2M | ||
| Q2 25 | $508.8M | $964.0M | ||
| Q1 25 | $423.8M | $926.1M | ||
| Q4 24 | $405.1M | $931.4M | ||
| Q3 24 | $477.6M | $909.7M | ||
| Q2 24 | $483.2M | $919.2M | ||
| Q1 24 | $513.1M | $909.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.3M | $26.2M |
| Free Cash FlowOCF − Capex | $14.5M | $14.5M |
| FCF MarginFCF / Revenue | 8.9% | 6.9% |
| Capex IntensityCapex / Revenue | 3.0% | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.3M | $26.2M | ||
| Q3 25 | $13.8M | $34.9M | ||
| Q2 25 | $-2.3M | $27.7M | ||
| Q1 25 | $-8.4M | $-7.9M | ||
| Q4 24 | $9.5M | $19.2M | ||
| Q3 24 | $35.7M | $24.3M | ||
| Q2 24 | $32.4M | $11.8M | ||
| Q1 24 | $6.0M | $-52.0M |
| Q4 25 | $14.5M | $14.5M | ||
| Q3 25 | $8.2M | $20.1M | ||
| Q2 25 | $-6.8M | $17.3M | ||
| Q1 25 | $-13.7M | $-17.3M | ||
| Q4 24 | $1.8M | $12.4M | ||
| Q3 24 | $28.2M | $15.5M | ||
| Q2 24 | $27.0M | $3.4M | ||
| Q1 24 | $372.0K | $-61.8M |
| Q4 25 | 8.9% | 6.9% | ||
| Q3 25 | 4.8% | 10.4% | ||
| Q2 25 | -4.2% | 9.3% | ||
| Q1 25 | -9.5% | -10.9% | ||
| Q4 24 | 1.2% | 7.5% | ||
| Q3 24 | 16.0% | 10.5% | ||
| Q2 24 | 14.3% | 2.3% | ||
| Q1 24 | 0.2% | -46.8% |
| Q4 25 | 3.0% | 5.6% | ||
| Q3 25 | 3.3% | 7.7% | ||
| Q2 25 | 2.8% | 5.6% | ||
| Q1 25 | 3.7% | 5.9% | ||
| Q4 24 | 5.1% | 4.2% | ||
| Q3 24 | 4.2% | 6.0% | ||
| Q2 24 | 2.8% | 5.7% | ||
| Q1 24 | 3.4% | 7.4% |
| Q4 25 | — | 4.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.93× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVEO
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
